A Case of Deep Venous Thrombosis in an HIV-Infected Patient despite Therapeutic Anticoagulation

Authors

  • Wajeeha Aiman Saint Michael’s Medical Center, New York College of Medicine, Newark, NJ, USA
  • Muhammad Ashar Ali Saint Clare’s and St. Mary’s General Hospital, Denville, NJ, USA
  • Navjot Grewal Saint Michael’s Medical Center, New York College of Medicine, Newark, NJ, USA
  • Nyan Bethel Saint Michael’s Medical Center, New York College of Medicine, Newark, NJ, USA
  • Andreas A. Savopoulos Saint Michael’s Medical Center, New York College of Medicine, Newark, NJ, USA
  • Gunwant Guron Saint Michael’s Medical Center, New York College of Medicine, Newark, NJ, USA

DOI:

https://doi.org/10.18502/ijhoscr.v18i2.15379

Keywords:

Deep venous thrombosis; Anti-coagulants; Human immunodeficiency virus (HIV); Enoxaparin

Abstract

Patients with human immunodeficiency virus (HIV) infection have an increased likelihood of venous thromboembolism (VTE) owing to factors such as acquired protein C and S deficiency, antiphospholipid antibody syndrome, and heightened levels of pro-inflammatory cytokines. This case report highlights an exceptionally uncommon occurrence of deep venous thrombosis in an HIV-infected patient receiving a therapeutic dose of enoxaparin. This underscores the need for cautious consideration of the risk of VTE in HIV-infected individuals, even with preventive or therapeutic anticoagulant treatment. Further research is recommended to investigate HIV as a potential risk factor of prophylactic anticoagulation.

Downloads

Published

2024-04-24

Issue

Volume (18) issue (2)

Section

Articles